Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Prepaid Assets (2023 - 2025)

CG Oncology (CGON) has disclosed Prepaid Assets for 3 consecutive years, with $15.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 23.38% year-over-year to $15.1 million, compared with a TTM value of $15.1 million through Dec 2025, up 23.38%, and an annual FY2025 reading of $15.1 million, up 23.38% over the prior year.
  • Prepaid Assets was $15.1 million for Q4 2025 at CG Oncology, up from $13.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $15.1 million in Q4 2025 and bottomed at $6.4 million in Q4 2023.
  • Average Prepaid Assets over 3 years is $11.7 million, with a median of $11.9 million recorded in 2024.
  • The sharpest move saw Prepaid Assets surged 92.07% in 2024, then rose 3.88% in 2025.
  • Year by year, Prepaid Assets stood at $6.4 million in 2023, then soared by 92.07% to $12.2 million in 2024, then grew by 23.38% to $15.1 million in 2025.
  • Business Quant data shows Prepaid Assets for CGON at $15.1 million in Q4 2025, $13.5 million in Q3 2025, and $11.4 million in Q2 2025.